-
1.
公开(公告)号:US20230181746A1
公开(公告)日:2023-06-15
申请号:US17925776
申请日:2021-05-17
Inventor: Daiqing LIAO , Yufeng XIAO , Xuan ZHANG , Guangrong ZHENG
Abstract: In one aspect, the disclosure relates to benzoylhydrazide-derived PROTACs that are highly effective at degrading HDAC3 and that are also capable of targeting, to a lesser extent, other HDAC isoforms, methods of making same, pharmaceutical compositions comprising same, and methods of treating cancers including hematologic cancers, breast cancer, other malignancies, and other serious diseases involving aberrant HDAC activity using the same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.